Cargando…
Non-clinical safety evaluation of a novel pharmaceutical salt, rosuvastatin ethanolamine, in Wistar rats
Rosuvastatin, a second generation 3-Hydroxy-3-Methyl Glutaryl Coenzyme-A reductase inhibitor, is widely used for the management of hypercholesterolemia. Rosuvastatin ethanolamine, developed by Cadila Healthcare Ltd., is a novel, chemically stable, and pharmaceutically acceptable salt, having better...
Autores principales: | Vaghasiya, Jigneshkumar, Patel, Satyam, Patel, Sudhir, Kadam, Shekhar, Ranvir, Ramchandra, Patel, Harilal, Sundar, Rajesh, Jain, Mukul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Slovak Toxicology Society SETOX
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061451/ https://www.ncbi.nlm.nih.gov/pubmed/32189982 http://dx.doi.org/10.2478/intox-2019-0002 |
Ejemplares similares
-
Evaluation of Adverse Effects of Lisinopril and Rosuvastatin on Hematological and Biochemical Analytes in Wistar Rats
por: Dodiya, Hardik, et al.
Publicado: (2013) -
Evaluation of Cardioprotective Effect of 3,5,3′-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity
por: Mishra, Vinay, et al.
Publicado: (2011) -
Evaluation of acute physiological and molecular alterations in surgically developed hypothyroid Wistar rats
por: Patel, Maulik, et al.
Publicado: (2013) -
Influence of estrous stages on electrocardiography, clinical pathology and ovarian weight of experimental beagle dogs: a retrospective analysis
por: SHAH, Chitrang, et al.
Publicado: (2019) -
Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet
por: Giri, Suresh R., et al.
Publicado: (2023)